Skip to main content
. 2022 Aug 7;25(6):989–1001. doi: 10.1007/s10120-022-01326-5

Table 2.

One- year-, 3-year-, and 5-year survival in histologically confirmed gastric adenocarcinoma (non-cardia and cardia) stratified by treatment during 1987–2016

Gastric non- cardia adenocarcinoma Gastric cardia adenocarcinoma
Patients Survival in % Patients Survival in %
Calendar period Number (%) 1 year 3 years 5 years Number (%) 1 year 3 years 5 years
All patients
 1987–1991 4486 (24.0) 38 21 17 677 (18.7) 34 14 10
 1992–1996 3720 (19.9) 40 20 18 676 (18.7) 36 16 12
 1997–2001 3135 (16.8) 41 23 19 657 (18.2) 40 18 13
 2002–2006 2928 (15.6) 41 22 17 551 (15.2) 40 16 12
 2007–2011 2552 (13.6) 42 23 17 612 (16.9) 44 20 14
 2012–2016 1892 (10.1) 40 23 16 444 (12.3) 50 24 18
Surgery
 1987–1991 2051 (24.7) 62 37 29 270 (20.5) 54 23 16
 1992–1996 1817 (21.9) 66 40 31 280 (21.2) 58 31 24
 1997–2001 1505 (18.1) 69 43 35 271 (20.5) 68 37 28
 2002–2006 1293 (15.6) 71 43 35 171 (13.0) 76 44 36
 2007–2011 995 (12.0) 77 49 37 176 (13.3) 90 57 43
 2012–2016 632 (7.6) 77 49 38 152 (11.5) 86 52 40
No surgery
 1987–1991 2435 (23.4) 18 8 7 407 (17.7) 20 7 5
 1992–1996 1903 (18.3) 16 7 6 396 (17.2) 20 4 4
 1997–2001 1630 (15.6) 16 5 4 386 (16.8) 20 4 2
 2002–2006 1635 (15.7) 17 5 3 380 (16.5) 23 3 2
 2007–2011 1557 (14.9) 20 6 4 436 (19.0) 26 5 3
 2012–2016 1260 (12.1) 22 6 4 292 (12.7) 32 9 7